Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2007 1
2015 1
2016 2
2017 2
2018 1
2020 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty.
Broquetas T, Hernandez JJ, Garcia-Retortillo M, Canillas L, Puigvehí M, Cañete N, Coll S, Viu A, Garrido E, Mico M, Bessa X, Carrión JA. Broquetas T, et al. Among authors: hernandez jj. Dig Liver Dis. 2022 Aug;54(8):1044-1051. doi: 10.1016/j.dld.2021.12.017. Epub 2022 Jan 19. Dig Liver Dis. 2022. PMID: 35063365 Free article.
Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes.
Redondo-Pachón D, Pérez-Sáez MJ, Mir M, Gimeno J, Llinás L, García C, Hernández JJ, Yélamos J, Pascual J, Crespo M. Redondo-Pachón D, et al. Among authors: hernandez jj. Hum Immunol. 2018 Jun;79(6):424-431. doi: 10.1016/j.humimm.2018.02.014. Epub 2018 Mar 7. Hum Immunol. 2018. PMID: 29524568
Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients.
Broquetas T, Garcia-Retortillo M, Micó M, Canillas L, Puigvehí M, Cañete N, Coll S, Viu A, Hernandez JJ, Bessa X, Carrión JA. Broquetas T, et al. Among authors: hernandez jj. World J Hepatol. 2020 Nov 27;12(11):1076-1088. doi: 10.4254/wjh.v12.i11.1076. World J Hepatol. 2020. PMID: 33312431 Free PMC article. Clinical Trial.
Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach.
Nomdedéu JF, Puigdecanet E, Bussaglia E, Hernández JJ, Carricondo M, Estivill C, Martí-Tutusaus JM, Tormo M, Zamora L, Serrano E, Perea G, de Llano MPQ, García A, Sánchez-Ortega I, Ribera JM, Nonell L, Aventin A, Solé F, Brunet MS, Sierra J. Nomdedéu JF, et al. Among authors: hernandez jj. Hematol Oncol. 2017 Dec;35(4):778-788. doi: 10.1002/hon.2304. Epub 2016 May 3. Hematol Oncol. 2017. PMID: 27140599
[Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients].
Rivero A, López-Cortés L, Castillo R, Verdejo J, García MA, Martínez-Marcos FJ, Díez F, Escribano JC, Canueto J, Lozano F, Pasquau J, Hernández JJ, Márquez M, Kindelán JM; Grupo Andaluz para el estudio de las Enfermedades Infecciosas (GAEI). Rivero A, et al. Among authors: hernandez jj. Enferm Infecc Microbiol Clin. 2007 May;25(5):305-10. doi: 10.1157/13102265. Enferm Infecc Microbiol Clin. 2007. PMID: 17504683 Clinical Trial. Spanish.
[Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy].
Rivero A, López-Cortés L, Castillo R, Lozano F, García MA, Díez F, Escribano JC, Canueto J, Pasquau J, Hernández JJ, Polo R, Martínez-Marcos FJ, Kindelán JM, Rey R; Grupo Andaluz para el estudio de las Enfermedades Infecciosas (GAEI). Rivero A, et al. Among authors: hernandez jj. Enferm Infecc Microbiol Clin. 2003 Jun-Jul;21(6):287-92. doi: 10.1016/s0213-005x(03)72942-5. Enferm Infecc Microbiol Clin. 2003. PMID: 12809582 Clinical Trial. Spanish.